510(k) Report

510(k) · Cleared

Cleared

Randox Creatinine

K973993510(k) TraditionalCleared Mar 6, 1998136-day reviewClass II21 CFR 862.1225

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Randox Laboratories, Ltd. · CGX Alkaline Picrate, Colorimetry, Creatinine

Cleared on Mar 6, 1998 after a 136-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 5 later devices descend from it.

Decided
Mar 6, 1998
Review
136 days
Class
Class II
Product code
CGX
Recalls
None
Predicates
0

5 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2007: 1 descendant cleared2021: 1 descendant cleared2016: 1 descendant cleared2024: 1 descendant cleared2025: 1 descendant cleared1995200020052010201520202025
  1. This deviceK973993 Randox CreatinineRandox Laboratories, Ltd. · 1998
  2. Descendant · cites it directly · 4 of its ownK070727 Advia Chemistry Enzymatic Creatinine_2Siemens Medical Solutions Diagnostics · 2007 · Recalled
  3. Descendant · 2 generations on · 2 of its ownK161494 Atellica CH Creatinine_2 (Crea_2), Atellica CH Chemistry Calibrator…Siemens Healthcare Diagnostics, Inc. · 2016 · Recalled
  4. Descendant · 3 generations on · 1 of its ownK242685 Atellica® CH Creatinine_3 (Crea3)Siemens Healthcare Diagnostics, Inc. · 2024
  5. Descendant · 4 generations on · 0 of its ownK251058 Tru Kidney Health Test Panel; Tru AnalyzerTruvian Health · 2025
  6. Descendant · 2 generations on · 0 of its ownK212223 Atellica CH Enzymatic Creatinine_3 (ECre3)Siemens Healthcare Diagnostics, Inc. · 2021

Most influential descendants

Showing 5 of 5 · See all
  • K070727Advia Chemistry Enzymatic Creatinine_2Siemens Medical Solutions Diagnostics · 2007 · cites it directly4descendants
  • K161494Atellica CH Creatinine_2 (Crea_2), Atellica CH Chemistry Calibrator (CHEM CAL)Siemens Healthcare Diagnostics, Inc. · 2016 · 2 generations on2descendants
  • K242685Atellica® CH Creatinine_3 (Crea3)Siemens Healthcare Diagnostics, Inc. · 2024 · 3 generations on1descendant
  • K251058Tru Kidney Health Test Panel; Tru AnalyzerTruvian Health · 2025 · 4 generations on0descendants
  • K212223Atellica CH Enzymatic Creatinine_3 (ECre3)Siemens Healthcare Diagnostics, Inc. · 2021 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K973993Randox CreatinineRandox Laboratories, Ltd.1998—
+1K070727Advia Chemistry Enzymatic Creatinine_2Siemens Medical Solutions Diagnostics20075
+2K161494Atellica CH Creatinine_2 (Crea_2), Atellica CH Chemistry Calibrator (CHEM CAL)Siemens Healthcare Diagnostics, Inc.20161
+3K242685Atellica® CH Creatinine_3 (Crea3)Siemens Healthcare Diagnostics, Inc.2024—
+4K251058Tru Kidney Health Test Panel; Tru AnalyzerTruvian Health2025—
+2K212223Atellica CH Enzymatic Creatinine_3 (ECre3)Siemens Healthcare Diagnostics, Inc.2021—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
201610
202110
202410
202510
FIG. 1 — Lineage of K973993, 1998–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CGX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CGX device

  1. #1 K242685 Atellica® CH Creatinine_3 (Crea3)score 12.1 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (5)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K070727Advia Chemistry Enzymatic Creatinine_2Siemens Medical Solutions Diagnostics20074

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K070727 (Siemens Medical Solutions Diagnostics, 2007) has gone furthest, with 4 descendants of its own.

How does its category compare?

All CGX devices

CGX Alkaline Picrate, Colorimetry, Creatinine: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CGX

1in 2025

2007: 42009: 12012: 12013: 12014: 22016: 12022: 12024: 22025: 12026 (partial year): 1
2007high 4 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CGX

25in 2007

2007: 25 days median
2007high 25 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CGX

2in 2016

2008: 12009: 22010: 22011: 12012: 22016: 22026 (partial year): 1
2007high 2 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CGX

34in 2025

2007: 152008: 272009: 52010: 52011: 322012: 132013: 242014: 132015: 132016: 32017: 212018: 142019: 252020: 192021: 132022: 232023: 192024: 322025: 34
2007high 34 (2025) · low 3 (2016)2025

MAUDE reports naming product code CGX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007425015
20080—127
20091—25
20100—25
20110—132
20121—213
20131—024
20142—013
20150—013
20161—23
20170—021
20180—014
20190—025
20200—019
20210—013
20221—023
20230—019
20242—032
20251—034
20261—1—

What is it indicated for?

The Randox Laboratories Limited Creatinine Test Kit is an in vitro diagnostic reagent for the quantitative determination of creatinine in human serum and plasma. The method is based on the reaction of creatinine with picrate in an alkaline environment (Jaffe) to produce a coloured complex. Creatinine is measured primarily to assess kidney function.

This test kit must‘be used by suitably qualified laboratory personnel under appropriate laboratory conditions.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K973993: Randox Creatinine.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K973993

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026